The Impact of Antibacterial Therapy on Clinical Outcomes and Intestinal Microbiota in Children with Acute Bacterial Diarrhea

Authors

  • Khadjaeva Dilbar Khamidovna Tashkent State Medical University

DOI:

https://doi.org/10.31149/ijimm.v4i2.2695

Keywords:

acute intestinal infections (AII), children, antibiotic resistance, antibacterial therapy, microbiota, etiotropic treatment, treatment optimization, pathogens

Abstract

The constant variability of microbial sensitivity to widely used antibiotics and the rise of antibiotic-resistant strains of pathogens in acute intestinal infections necessitate the use of antibacterial drugs that demonstrate the highest sensitivity to the identified pathogen while minimizing side effects [6, 8, 9]. Acute intestinal infections (AII) remain one of the most prevalent infectious pathologies in childhood, accompanied by significant morbidity and a high risk of complications [1, 2]. Alterations in the composition of the microbiota can negatively impact a child's immune status and contribute to an increased frequency of recurrent intestinal infections [7, 8].

References

[1] Kagan A.V., Belyaeva I.A. Influence of antibacterial therapy on intestinal microflora in children // Pediatrics. – 2019. – No. 4. – P. 45–50.

[2] Rumyantsev A.G., Samsygina G.A. Modern aspects of treatment of acute intestinal infections in children // Questions of Modern Pediatrics. – 2020. – Vol. 19, No. 2. – P. 120–126.

[3] Shakhovskaya A.K., Plakhova N.I. Clinical-microbiological efficacy of antibacterial therapy for acute intestinal infections in children // Pediatric Infections. – 2021. – No. 1. – P. 33–38.

[4] Korneyeva O.N., Safronova L.A. Changes in intestinal microflora during antibacterial therapy in children // Russian Bulletin of Perinatology and Pediatrics. – 2020. – No. 3. – P. 58–63.

[5] Vorobyeva L.I., Zakharova I.N. Rational use of antibacterial drugs in acute intestinal infections in children // Pediatric Pharmacology. – 2019. – No. 2. – P. 72–78.

[6] Zaitseva S.V. Disorders of intestinal microflora in children with infectious diseases // Nutrition Issues. – 2018. – No. 6. – P. 41–47.

[7] Thapar N., Sanderson I.R. Diarrhoea in children: an interface between developing and developed countries // The Lancet. – 2018. – Vol. 391, No. 10128. – P. 2463–2475.

[8] Szajewska H., Guarino A. Antibiotics for acute infectious diarrhea in children: updated systematic review // Alimentary Pharmacology & Therapeutics. – 2022. – Vol. 55, No. 2. – P. 215–224.

[9] Shane A.L., Crump J.A. Management of infectious diarrhea in children: update // Clinical Infectious Diseases. – 2023. – Vol. 76, No. 3. – P. 512–520.

[10] Thapar N., Sanderson I.R. Diarrhoea and gut microbiota in children: modern concepts // The Lancet Child & Adolescent Health. – 2024. – Vol. 8, No. 1. – P. 34–45.

Downloads

Published

2026-02-23

How to Cite

Khamidovna, K. D. (2026). The Impact of Antibacterial Therapy on Clinical Outcomes and Intestinal Microbiota in Children with Acute Bacterial Diarrhea. International Journal of Integrative and Modern Medicine, 4(2), 163–164. https://doi.org/10.31149/ijimm.v4i2.2695

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.